How Oncogenes MYC and PAX3-FKHR Affect Cell Death in Rhabdomyosarcoma
Author Information
Author(s): Taylor Alan C, Schuster Katja, McKenzie Pamela P, Harris Linda C
Primary Institution: St. Jude Children's Research Hospital
Hypothesis
The study aims to evaluate how MYC and PAX3-FKHR oncogenes influence p53-mediated apoptosis in rhabdomyosarcoma cells.
Conclusion
The study concludes that the cooperation between p53 and oncogenes to induce apoptosis depends on the specific oncogene expressed.
Supporting Evidence
- MYC can enhance cell death when combined with wild-type p53.
- PAX3-FKHR does not significantly enhance p53-mediated apoptosis.
- Both MYC and p53 are required for maximal cell death in rhabdomyosarcoma cells.
Takeaway
This study shows that for cells to die, they need a special combination of proteins, and just having one of them isn't enough.
Methodology
Rhabdomyosarcoma cells were modified to express MYC and PAX3-FKHR, and their response to wild-type p53 was evaluated through various assays.
Limitations
The study primarily focuses on specific cell lines and may not represent all rhabdomyosarcoma cases.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website